NEOGENOMICS INC Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Neogenomics Inc quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Neogenomics Inc Debt-to-equity for the quarter ending September 30, 2024 was 79.1 %, a 4.01% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 79.1 +3.05 +4.01% Sep 30, 2024
Q2 2024 78.2 +3.13 +4.17% Jun 30, 2024
Q1 2024 77.7 +3.99 +5.42% Mar 31, 2024
Q4 2023 77.1 +4.73 +6.54% Dec 31, 2023
Q3 2023 76 +5.09 +7.18% Sep 30, 2023
Q2 2023 75.1 +5.53 +7.96% Jun 30, 2023
Q1 2023 73.7 +5.79 +8.53% Mar 31, 2023
Q4 2022 72.4 +3.22 +4.66% Dec 31, 2022
Q3 2022 70.9 +6.54 +10.2% Sep 30, 2022
Q2 2022 69.5 +10.3 +17.4% Jun 30, 2022
Q1 2022 67.9 +14.4 +26.9% Mar 31, 2022
Q4 2021 69.1 +25.3 +57.6% Dec 31, 2021
Q3 2021 64.4 +20.9 +48.2% Sep 30, 2021
Q2 2021 59.2 +16 +37.1% Jun 30, 2021
Q1 2021 53.5 +11 +25.7% Mar 31, 2021
Q4 2020 43.9 -1.93 -4.21% Dec 31, 2020
Q3 2020 43.5 -6.53 -13.1% Sep 30, 2020
Q2 2020 43.2 -9.15 -17.5% Jun 30, 2020
Q1 2020 42.5 -22.9 -35% Mar 31, 2020
Q4 2019 45.8 -22.8 -33.3% Dec 31, 2019
Q3 2019 50 -25.7 -34% Sep 30, 2019
Q2 2019 52.4 -37.2 -41.5% Jun 30, 2019
Q1 2019 65.4 -17.9 -21.5% Mar 31, 2019
Q4 2018 68.6 -16.4 -19.3% Dec 31, 2018
Q3 2018 75.7 -12.1 -13.8% Sep 30, 2018
Q2 2018 89.6 +10.7 +13.5% Jun 30, 2018
Q1 2018 83.3 +12.9 +18.4% Mar 31, 2018
Q4 2017 85 +23.6 +38.3% Dec 31, 2017
Q3 2017 87.8 +34.4 +64.4% Sep 30, 2017
Q2 2017 78.9 +27.4 +53.3% Jun 30, 2017
Q1 2017 70.4 +21.3 +43.4% Mar 31, 2017
Q4 2016 61.4 +15.9 +35% Dec 31, 2016
Q3 2016 53.4 +18.2 +51.6% Sep 30, 2016
Q2 2016 51.5 +16.7 +48.1% Jun 30, 2016
Q1 2016 49.1 +8.69 +21.5% Mar 31, 2016
Q4 2015 45.5 -3.41 -6.97% Dec 31, 2015
Q3 2015 35.2 -26.7 -43.1% Sep 30, 2015
Q2 2015 34.7 -49 -58.5% Jun 30, 2015
Q1 2015 40.4 -40.5 -50% Mar 31, 2015
Q4 2014 48.9 -29.4 -37.5% Dec 31, 2014
Q3 2014 61.9 -34.8 -35.9% Sep 30, 2014
Q2 2014 83.8 -41 -32.9% Jun 30, 2014
Q1 2014 80.9 -76.6 -48.6% Mar 31, 2014
Q4 2013 78.3 -131 -62.5% Dec 31, 2013
Q3 2013 96.7 -113 -53.8% Sep 30, 2013
Q2 2013 125 -85.2 -40.6% Jun 30, 2013
Q1 2013 158 -61.9 -28.2% Mar 31, 2013
Q4 2012 209 Dec 31, 2012
Q3 2012 209 Sep 30, 2012
Q2 2012 210 Jun 30, 2012
Q1 2012 219 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.